all report title image
  • Published In : Nov 2023
  • Code : CMI930
  • Pages : 180
  • Formats :
      Excel/PDF
  • Industry : Pharmaceutical
N/A

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Disease Type
      • Market Snippet, By Drug Class
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Myeloproliferative Neoplasms Treatment Market – COVID-19 Impact Analysis
    • Economic Impact
    • COVID-19 Epidemiology
    • Impact on Supply and Demand
  5. Global Myeloproliferative Neoplasms Treatment Market, By Disease Type, 2018-2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019–2030
      • Segment Trends
    • Essential Thrombocythemia (ET)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Myelofibrosis (MF)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Polycythemia Vera (PV)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
  6. Global Myeloproliferative Neoplasms Treatment Market, By Drug Class, 2018 – 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019–2030
      • Segment Trends
    • Tyrosine Kinase Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Janus Kinase Inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Antimetabolites
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
      • Segment Trends
  7. Global Myeloproliferative Neoplasms Treatment Market, By Distribution Channel, 2018 – 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019–2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2018 – 2030, (US$ Bn)
  8. Global Myeloproliferative Neoplasms Treatment Market, By Region, 2018 – 2030, (US$ Bn)
    • Introduction
      • Market Share Analysis, 2023 and 2030 (%)
      • Y-o-Y Growth Analysis, 2019–2030
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2018 –2030, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Disease Type, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 –2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018–2030, (US$ Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Region/Country,  2018 –2030, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • PharmaEssentia Corporation
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Bristol Myers Squibb
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Takeda Pharmaceutical Company Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Incyte
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Teva Pharmaceutical Industries Ltd
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • F. Hoffmann-La Roche AG
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Gamida Cell
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sierra Oncology, Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • CTI BioPharma Corp
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Imago BioSciences
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Constellation Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 26 figures on “Global Myeloproliferative Neoplasm Treatment Market” – Global forecast to 2030

View Our Licence Options

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.